Robba and colleagues' description of three distinct radiological phenotypes of severe Coronavirus Disease 2019 (COVID-19) pneumonia and their suggestion that the phenotype of COVID-19 should define management is extremely important ([@bib0035]). Phenotype 1 is associated with multiple, focal, sub-pleural, ground glass opacities. This may correlate with the so-called "Type L" (i.e. low elastance, low lung weight and little response to lung recruitment) clinical phenotype of COVID-19 ([@bib0020]).

This phenotype was more common if patients were intubated promptly ([@bib0035]). Patients who received prolonged non-invasive ventilation were more likely to have radiological features more typical of ARDS (phenotype 2 or 3). Thus, disease progression and some features of phenotype 2 and 3 may be due, at least in part, to patient self-induced lung injury. Therefore, defining and targeting treatment to the specific pathologies responsible for the various phenotypes of COVID-19 pneumonia could prevent disease progression and improve outcomes.

Radiological phenotype 1 and clinical Type L COVID-19 may be associated with right-to-left (RTL) shunt ([@bib0020], [@bib0025]; [@bib0030]; [@bib0035]). Patients with COVID-19 often have a high RTL shunt fraction (0.50 ± 0.11) despite having near normal lung compliance (50.2 ± 14.3 ml/cmH~2~O; [@bib0025]). This may represent increased intra-pulmonary shunt (IPS) due to pulmonary endothelial dysfunction and dysregulated hypoxic vasoconstriction ([@bib0020], [@bib0025]). However, the pathogenesis of COVID-19 also involves pulmonary microvascular thrombosis and the incidence of venous thromboembolism is very high ([@bib0010]); phenomena which should increase dead space rather than IPS.

So, the anatomical substrate for RTL shunt in patients with COVID-19 could be extra-pulmonary (EPS) as well as intra-pulmonary ([@bib0030]). Extra-pulmonary shunt is often due to inter-atrial defects; the most common of which is patent foramen ovale (PFO; prevalence 20--30 %) ([@bib0005]).

Robba and colleagues' suggestion to consider pulmonary thromboembolic disease (PE) is also relevant ([@bib0035]). Defining the incidence of PE, intra-pulmonary shunt, pulmonary arterio-venous malformations, PFO, atrial septal defects and atrial septal aneurysms in patients with phenotype 1 and Type L COVID-19 would greatly advance the understanding of the pathogenesis of COVID-19.

Correlating the radiological features of patients with COVID-19 pneumonia with their blood gases and lung mechanics could revolutionize the approach to management. Such a paradigm shift is urgently required because many patients with COVID-19 do not improve with the standard approach to treatment of acute respiratory distress syndrome (ARDS) ([@bib0020], [@bib0025]; [@bib0030]).

Further clinically relevant radiological analysis could be informed by "triple rule-out'' computed tomography angiography (TRO-CTA). This can detect acute aortic syndrome, coronary artery disease, PE, and other pulmonary pathology, with a single acquisition ([@bib0045]). Some CTA protocols can provide detailed anatomic information about the size, morphologic features, and grade of shunt of interatrial defects including PFO ([@bib0040]).

Access to CT may be restricted during the pandemic and in young patients there may be concerns about radiation doses ([@bib0015]). So, an alternative strategy to screen for RTL shunt could include saline microbubble contrast echocardiography. This minimally invasive, bedside test can be used to detect, quantify and distinguish IPS and intra-cardiac shunt. Furthermore, serial bedside echocardiography could be used to track changes in RTL shunt with interventions and disease progression.

Detecting RTL shunt and defining its anatomical substrate can significantly change management. The standard approaches to refractory hypoxia and ARDS aim to reduce dead space and IPS. Careful positioning and medical management can reduce the need for ventilatory support in select patients with RTLEPS. However, blind application of interventions intended to reduce EPS could increase IPS, and vice versa. To achieve the best oxygenation with the least ventilatory support; the effects of any intervention on total RTL shunt (i.e. IPS and EPS) and dead space must be considered. Thus, in select high risk patients with COVID-19, percutaneous closure of inter-atrial defects could markedly improve hypoxia and prevent paradoxical embolization.

Correlation of the radiological features of COVID-19 with clinical phenotypes based on blood gases, lung mechanics and shunt could redefine management. Thus, identification of subtypes of COVID-19; targeting therapies (e.g. awake prone positioning, anticoagulation, inhaled nitric oxide, physiotherapy, lung recruitment manoeuvres, ventilatory support) to the specific underlying cause(s); and monitoring the effect of interventions on clinical parameters and shunt could improve outcomes.
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